01.04.2025This state-of-the-art facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’, continuing collaborative efforts to support the development and commercialisation of next-generation therapies. The new 23,680 square foot, multi-purpose facility will enhance Croda’s capabilities in producing critical components for drug delivery systems, including lipids used for delivery of nucleic acid-based therapeutics, mRNA vaccines, gene editing therapies, and novel cancer treatments. As the pharmaceutical industry accelerates innovation in biologics, our Lamar facility will play a key role in supporting advancements that improve global health outcomes.
02.04.2025This state-of-the-art facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’, continuing collaborative efforts to support the development and commercialisation of next-generation therapies. The new 23,680 square foot, multi-purpose facility will enhance Croda’s capabilities in producing critical components for drug delivery systems, including lipids used for delivery of nucleic acid-based therapeutics, mRNA vaccines, gene editing therapies, and novel cancer treatments. As the pharmaceutical industry accelerates innovation in biologics, our Lamar facility will play a key role in supporting advancements that improve global health outcomes.
02.04.2025The PSCI audit program assesses supplier partner performance against these principles, international standards, agreements, and local regulations in areas such as ethics, labor law, healthcare, safety, environmental protection, and management systems.
01.04.2025The PSCI audit program assesses supplier partner performance against these principles, international standards, agreements, and local regulations in areas such as ethics, labor law, healthcare, safety, environmental protection, and management systems.
02.04.2025Bionova Scientific, a boutique commercial-scale biologics contract development and manufacturing organization (CDMO), announced that Bionique Testing Laboratories, a leading Contract Research Organization (CRO), has been appointed as the preferred provider for mycoplasma testing services...
03.04.2025Bionova Scientific, a boutique commercial-scale biologics contract development and manufacturing organization (CDMO), announced that Bionique Testing Laboratories, a leading Contract Research Organization (CRO), has been appointed as the preferred provider for mycoplasma testing services...
03.04.2025KRAS-specific synthetic lethal targets identified through Ryvu's ONCO Prime platform show promising potential for new therapeutic options for colorectal cancer (CRC) patients.
03.04.2025Dr. Stefan Koch, CEO von MCM Klosterfrau Vertriebsgesellschaft mbH, wird Vorsitzender des Landesvorstandes.
04.04.2025Dr. Stefan Koch, CEO von MCM Klosterfrau Vertriebsgesellschaft mbH, wird Vorsitzender des Landesvorstandes.
04.04.2025Merck und Zebra haben eine Zusammenarbeit angekündigt, um Herausforderungen bei Produktprüfung, Authentizität und Vertrauen zu lösen...
Sie sehen Artikel 19661 bis 19670 von insgesamt 19834